Research suggests that Amla (Indian gooseberry, Phyllanthus emblica) may offer several properties relevant to anti-aging, including antioxidant, anti-inflammatory, and cellular protective effects, based on a combination of laboratory studies and a narrative review. A 2024 review of the fruit's phytochemical profile concluded that its broad range of bioactive compounds supports potential anti-aging and disease-preventive applications, while a 2019 cell-based study found that an Amla extract appeared to reduce oxidative stress and support mitochondrial health in retinal cells modeled on age-related macular degeneration. A 2012 animal and cell culture study additionally found immune-stimulating activity, which may be indirectly relevant to age-related immune decline. The current body of evidence is limited primarily to in vitro experiments, animal models, and a descriptive review rather than clinical trials in humans, so while findings are generally supportive in direction, they should be interpreted cautiously until further research — particularly randomized controlled trials — is conducted.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Recent Insights into the Morphological, Nutritional and Phytochemical Propert... | Review | 2024 | Supports | 100 |
| Nutraceutical effects of Emblicaofficinalis in age-related macular degeneration. | Other | 2019 | Supports | 95 |
| The Phyllanthus emblica L. infusion carries immunostimulatory activity in a m... | Other | 2012 | Neutral | 90 |